REC-4881

· Recursion Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for REC-4881, covering 2026-02-23 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP) [Phase 1, Phase 2]